eCite Digital Repository

Beta-blockers in asthma


Bereznicki, L and Bereznicki, B, Beta-blockers in asthma, Australian Pharmacist, 32, (5) pp. 54-57. ISSN 0728-4632 (2013) [Contribution to Refereed Journal]

Restricted - Request a copy

Copyright Statement

Copyright 2013 Pharmaceutical Society of Australia Ltd

Official URL:


Australia has one of the highest prevalence rates for asthma in the world, affecting around 15% of the population. Short-acting beta2 agonists (SABAs) have a longstanding role as the main treatment option for the acute relief of symptoms, while more recently long-acting beta2 agonists (LABAs) have been recommended for use as add-on therapy to inhaled corticosteroids for the prevention of symptoms.

Item Details

Item Type:Contribution to Refereed Journal
Keywords:beta-blockers, asthma
Research Division:Biomedical and Clinical Sciences
Research Group:Pharmacology and pharmaceutical sciences
Research Field:Clinical pharmacy and pharmacy practice
Objective Division:Health
Objective Group:Other health
Objective Field:Other health not elsewhere classified
UTAS Author:Bereznicki, L (Professor Luke Bereznicki)
UTAS Author:Bereznicki, B (Dr Bonnie Bereznicki)
ID Code:84835
Year Published:2013
Deposited By:Pharmacy
Deposited On:2013-06-04
Last Modified:2014-06-13
Downloads:1 View Download Statistics

Repository Staff Only: item control page